Search for: "Pfizer Pharmaceutic, Inc."
Results 181 - 200
of 667
Sort by Relevance
|
Sort by Date
31 Jul 2013, 7:04 pm
Wyeth Pharmaceuticals Inc., (now owned by Pfizer) a pharmaceutical company has agreed to pay $490.9 million to resolve the unlawful marketing of the prescription drug Rapamune. [read post]
31 Jul 2013, 7:04 pm
Wyeth Pharmaceuticals Inc., (now owned by Pfizer) a pharmaceutical company has agreed to pay $490.9 million to resolve the unlawful marketing of the prescription drug Rapamune. [read post]
29 Jul 2013, 4:00 am
Legal Feeds Blog Legal PostClass-action suit against Pfizer Canada over anti-smoking drug Champix to proceedOTTAWA — A class-action lawsuit against pharmaceutical giant Pfizer Canada over its anti-smoking drug Champix will proceed, an Ontario Superior Court has ruled. [read post]
26 Jun 2013, 6:30 am
Patent Litigation Settlement RoundupOn November 8, 2012, Mylan Inc. [read post]
14 Jun 2013, 12:13 pm
Merrell Dow Pharmaceuticals, Inc., 911 F.2d 941, 948 (3d Cir. 1990). [read post]
5 Jun 2013, 5:29 am
American Medical Systems, Inc., 958 F. [read post]
17 May 2013, 10:55 am
Warner-Lambert and Pfizer Inc. entered into a co-marketing agreement and the companies began distributing and selling Lipitor throughout the U.S.in 1997. [read post]
17 May 2013, 9:09 am
In Pfizer Inc. et al. v. [read post]
14 May 2013, 10:50 am
Ranbaxy USA Inc., the American subsidiary of Ranbaxy Laboratories Limited, an Indian generic pharmaceutical maker, has agreed to pay $500 million to settle fines related to claims that it made false statements to the FDA about its manufacturing practices abroad and sold substandard medications and pay penalties. [read post]
9 May 2013, 5:34 am
The lawsuit names Pfizer, as well as two different generic drug manufacturers - Actavis Elizabeth and Teva Pharmaceuticals - in the U.S. [read post]
22 Apr 2013, 2:43 pm
Pfizer – $491 million Pfizer announced a $491 million charge to settle a case initially filed against Wyeth (a drug company acquired by Pfizer in 2009). [read post]
19 Apr 2013, 5:35 pm
Ortho Pharmaceutical Corp. [read post]
1 Apr 2013, 8:29 am
” Upon receiving this reissue patent, Pfizer immediately filed a lawsuit against Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals Inc.; Watson Laboratories, Inc.; Lupin Pharmaceuticals, USA, Inc.; Apotex Corp.; and Apotex, Inc. in the United States District Court for the Eastern District of Virginia for infringement of the reissue patent. [read post]
23 Mar 2013, 4:26 pm
Nursing home to pay $2.7M for False Claims Act violations, Legal Newsline, March 25, 2013 Tennessee-Based Therapy Providers to Pay $2.7 Million to Resolve False Claims Act Allegations, US DOJ, March 8, 2013 More Blog Posts: Whistleblower Lawsuit Accuses Dialysis Company DaVita Inc. of Overbilling Medicare and Medicaid by Hundreds of Millions of Dollars, Boston Injury Lawyer Blog, December 22, 2013 $25M Whistleblower Settlement Reached in Hospice Fraud Case Against Odyssey Healthcare… [read post]
14 Mar 2013, 4:00 am
” otherwise “. . . the court may be heading into unknown waters without a chart.[429] An example of an application of this reading of Free World can be found in Pfizer Canada Inc. v. [read post]
10 Mar 2013, 9:59 pm
Searle LLC; Pfizer Asia Pacific PTE, LTD.; • Defendants: Lupin Pharmaceuticals, Inc.; Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals Inc.; Watson Laboratories, Inc.; Apotex Inc.; Apotex Corp. [read post]
11 Feb 2013, 3:04 pm
From our much-admired former guest Kat and respected blogger Norman Siebrasse comes news that the IPKat has been judicially cited by Hughes J of the Federal Court of Canada in Pfizer Canada Inc v Pharmascience Inc 2013 FC 120 at paragraph 75, for the Kat's explanation of the "Angora cat" approach to claim construction (the cited url is not exactly right -- it says "com-uk" rather than "co.uk"). [read post]
2 Feb 2013, 5:00 am
Plumlee is suing Pfizer Inc. for consumer fraud after taking the prescription antidepressant Zoloft for three years. [read post]
1 Feb 2013, 9:42 am
Pfizer, Inc., 877 F. [read post]
18 Jan 2013, 2:06 pm
The Decherts are too involved in this litigation to comment publicly.There aren’t many research-oriented pharmaceutical companies based in Alabama, and after last week’s execrable decision in Wyeth, Inc. v. [read post]
